The global cognitive wellness market is no longer a niche category — it is a multi-billion-dollar growth engine, and Sequoya Biotechnologies is positioning supplement brands to capture their share of it. With three ready-to-brand nootropic oil formulations now available for white-label and private-label manufacturing (Sequoya Biotechnologies), the company offers brands a fast track into one of the supplement industry’s fastest-growing segments.

A Market Moving at Double Digits

The global nootropics market was valued at USD 6.02 billion in 2025 and is projected to grow to USD 14.79 billion by 2034 at a CAGR of 10.5% (Fortune Business Insights). The broader brain health supplements market is tracking similarly, expected to grow from USD 10.48 billion in 2026 to USD 26.38 billion by 2035 at a CAGR of 10.8% (Market Research Future via EIN News).

Two very different consumer groups are converging on the same shelf: students and knowledge workers seeking sharper focus, and aging consumers prioritising memory and long-term cognitive health (GII Research). Population ageing, hybrid work, academic pressure, and heightened awareness of mental well-being are all accelerating demand for cognitive support solutions (GII Research).

Critically for brands, the industry is shifting away from stimulant-led “brain booster” pills toward holistic solutions that address focus, mood balance, sleep quality, and stress management as interconnected drivers of mental performance (Nutrition Insight). This is exactly the space Sequoya’s nootropic oil portfolio is designed to occupy.

Three Formulations, Three Consumer Need-States

Sequoya Biotechnologies’ nootropic oil portfolio covers the most in-demand consumer need-states in cognitive wellness — focus, memory, and stress balance — all delivered in an oil-based format designed for optimal bioavailability and absorption (Sequoya Biotechnologies).

Memory Improvement Nootropics Oil

A scientifically formulated blend of Chinese Schisandra, Rhodiola, Bacopa Monnieri, and Lion’s Mane extract in an MCT (coconut oil) base (Sequoya Biotechnologies). Each ingredient is positioned around a distinct cognitive pathway: Schisandra for reducing mental fatigue, Rhodiola for stress resilience and cognitive performance under pressure, Bacopa Monnieri for learning speed and memory, and Lion’s Mane for long-term brain health support (Sequoya Biotechnologies).

The ingredient choices align with strong market trends. Lion’s Mane is the fastest-growing segment in the functional mushroom market, which was valued at USD 34.62 billion in 2025 and is projected to reach USD 84.78 billion by 2035 (Precedence Research). The broader medicinal mushroom market, where cognitive support is the fastest-growing function at a projected 10.57% CAGR through 2031, further validates the demand for Lion’s Mane and Cordyceps-based formulations (Mordor Intelligence).

Focus & Memory Nootropics Oil

A formulation combining Bacopa, Lion’s Mane, Cordyceps, and Ashwagandha extract in MCT oil (Sequoya Biotechnologies). Positioned as a premium brain support formula, it is designed to support sharpened focus, enhanced memory, and mental stamina (Sequoya Biotechnologies). The inclusion of Cordyceps adds an energy and stamina positioning, while Ashwagandha contributes stress-resilience support without sedation — addressing the growing consumer preference for holistic cognitive solutions (Nutrition Insight).

Ashwagandha has emerged as one of the most sought-after adaptogenic ingredients globally. The ashwagandha market was valued at approximately USD 0.67 billion in 2025 and is projected to reach USD 1.75 billion by 2035, growing at a CAGR of 10.07% (SNS Insider). It was the third-most-purchased herbal supplement in the United States in 2024, with sales totalling USD 144 million (American Botanical Council via IFT). Cognitive and brain health applications for ashwagandha are projected to grow at the fastest CAGR of 12.89% through 2035 (SNS Insider).

Rest & Relax Nootropics Oil

A blend of Ashwagandha, Korean Ginseng, and Rhodiola extract in MCT oil, designed for stress support, recovery, and nervous system balance (Sequoya Biotechnologies). This formulation addresses the stress-and-sleep side of cognitive wellness — a segment that is expanding rapidly. The global stress relief supplements market reached USD 629.93 million in 2025 and is expected to grow to USD 1.07 billion by 2033, with adaptogens holding the largest ingredient share at approximately 28% (DataM Intelligence). The broader adaptogens market was estimated at USD 10.9 billion in 2024 and is projected to reach USD 16.3 billion by 2030 (Grand View Research via IFT).

The Oil Format Advantage

All three formulations are delivered in an MCT (coconut oil) base, a choice that is strategic rather than incidental. Sequoya Biotechnologies positions its oil-based format for bioavailability and absorption support, with flexible dosing via spray or pipette, multiple bottle sizes (30 ml, 50 ml, 100 ml, 1000 ml), and customisable flavours including orange, lemon, mint, and terpenes (Sequoya Biotechnologies).

For brands, the oil format also means differentiation — a premium, modern consumer experience that stands out on shelf and in e-commerce listings.

Quality as a Market Differentiator

The rapid growth of nootropic ingredients has created a quality challenge that works in favour of GMP-certified manufacturers. A 2025 study testing 30 Lion’s Mane supplements sold in the EU and UK found that more than half failed to meet their own label claims, with several containing little to no detectable active compounds (Vitafoods Insights). This underscores the market opportunity for brands that can demonstrate quality, potency, and batch-to-batch consistency (Vitafoods Insights).

Sequoya Biotechnologies manufactures all nootropic oil formulations in an EU GMP-certified facility, with ISO 22000 and HACCP certifications, rigorous QA/QC processes, and stability analysis (Sequoya Biotechnologies). With over 7 years of experience developing more than 600 custom private-label supplements for brands worldwide, the company offers end-to-end production from ingredient sourcing and R&D through to final product packaging — supporting both small-batch pilot runs and high-volume production for global distribution (Sequoya Biotechnologies).

What This Means for Supplement Brands

For brands evaluating entry or expansion in the cognitive wellness space, the positioning is clear:

• Speed to market: Ready-to-brand formulations can help shorten development timelines significantly compared to building from scratch (Sequoya Biotechnologies).
• Portfolio strategy: Three complementary formulations cover the full cognitive wellness spectrum — focus, memory, and stress balance — enabling brands to build a complete nootropic line rather than a single SKU (Sequoya Biotechnologies).
• Quality assurance: EU GMP manufacturing with full documentation addresses quality concerns in fast-growing nootropic categories (Sequoya Biotechnologies).
• Format differentiation: Oil-based delivery in MCT offers a premium positioning distinct from the saturated capsule market.
• Scalability: From small-batch pilot runs to high-volume global distribution, the manufacturing infrastructure supports brands at every stage of growth (Sequoya Biotechnologies).

The brain health supplements category is projected to grow from USD 10.48 billion in 2026 to USD 26.38 billion by 2035 (Market Research Future via EIN News). For supplement brands, the question is no longer whether to enter the nootropics space, but how quickly and with what quality assurance. Sequoya Biotechnologies’ three nootropic oil formulations offer a compelling answer to both.

To learn more about Sequoya Biotechnologies’ white-label nootropic oil portfolio or to discuss custom formulation development, contact the team at +48-731-563-111 (Europe) or sales@sequoyabio.com, or visit the product pages for Memory Improvement, Focus & Memory, and Rest & Relax nootropic oils.